O-mannosylation and protein maturation check-points represent therapeutic opportunities in BRAF fusion protein oncogenesis
Misek, S.; Borgenvik, A.; Christen, D.; Kyrila, G.; Zhang, A.; Reel, S.; Boisvert, M.; Cai, K.; Zhou, K.; Gonzales, E.; Goodale, A.; LazodelaVega, L.; Ragnoni, T.; Zohra, K.; Persky, N.; Abid, T.; Miglietta, E.; Vakhrushev, S.; Stumpe, M.; Jones, J.; Malinowski, S.; Elsadek, L.; Parikh, J.; Condurat, A.; Fultineer, A.; Choi, S. H.; Ozdemir, M.; Eisenbies, Z.; Lee, J.; Novikov, D.; Bahadur, S.; Apfelbaum, A.; Robinson, J.; Tang, K.; Maldera, A.; Bondeson, D.; Kwon, J.; Vallurupalli, M.; Jeon, H.; Pal, S.; Golub, T.; Hahn, W.; Fischer, E.; Boehm, J.; Dengjel, J.; Clausen, H.; Jabado, N.; Milde,
Show abstract
Fusions between protein-coding genes are common oncogenic drivers across cancers, typically pairing a proto-oncogene with partner that does not independently drive cancer. In all therapeutically actionable fusions, the proto-oncogene is the drug target, the contributions to oncogenicity of the fusion partner have largely been ignored. We studied the role of BRAF fusion partners and found that they are necessary for transformation. In the setting of KIAA1549::BRAF, the most common fusion protein across brain tumors, we found that KIAA1549 is necessary for the oncogenicity of KIAA1549::BRAF and engenders a striking and specific dependency on the protein O-mannosyltransferase complex (POMT1/2). Specifically, we show that genetic silencing or pharmacologic inhibition of the protein O-mannosyltransferase complex (POMT1/2) reverses fusion-induced transformation, thereby representing a novel and MAPK independent therapeutic target. Furthermore, POMT1/2 is required to glycosylate and enable maturation of the K::B fusion protein. These findings represent a proof-of-concept for targeting the partners in oncogenic fusions as a potential cancer therapeutic strategy.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cell polarity proteins promote macropinocytosis in response to metabolic stress 96%
- An integrative oncogene-dependency map identifies unique vulnerabilities of oncogenic EGFR, KRAS, and RIT1 in lung cancer 96%
- Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity. 96%
Similar papers in this journal
- NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas 97%
- Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma 96%
- p120 RasGAP and ZO-2 are essential for Hippo signaling and tumor suppressor function mediated by p190A RhoGAP 96%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.